{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T21:51:54Z","timestamp":1768513914079,"version":"3.49.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.npep.2019.101998","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T11:28:43Z","timestamp":1574422123000},"page":"101998","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Signaling molecules targeting cannabinoid receptors: Hemopressin and related peptides"],"prefix":"10.1016","volume":"79","author":[{"given":"Fengmei","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhong","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.npep.2019.101998_bb0005","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3390\/biom9040150","article-title":"Intracellular peptides in cell biology and pharmacology","volume":"9","author":"Araujo","year":"2019","journal-title":"Biomolecules."},{"issue":"44","key":"10.1016\/j.npep.2019.101998_bb0010","doi-asserted-by":"crossref","first-page":"36944","DOI":"10.1074\/jbc.M112.382481","article-title":"Identification and quantification of a new family of peptide Endocannabinoids (Pepcans) showing negative allosteric modulation at CB 1 receptors","volume":"287","author":"Bauer","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.npep.2019.101998_bb0015","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nn.3053","article-title":"Mitochondrial CB1 receptors regulate neuronal energy metabolism","volume":"15","author":"B\u00e9nard","year":"2012","journal-title":"Nat. Neurosci."},{"issue":"5","key":"10.1016\/j.npep.2019.101998_bb0020","doi-asserted-by":"crossref","first-page":"564","DOI":"10.2174\/187152710793361568","article-title":"Cannabinoid receptors and Endocannabinoids: role in Neuroinflammatory and neurodegenerative disorders","volume":"9","author":"Bisogno","year":"2010","journal-title":"CNS Neurol Disord - Drug Targets."},{"issue":"8","key":"10.1016\/j.npep.2019.101998_bb0025","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.peptides.2005.03.026","article-title":"Hypotensive effects of hemopressin and bradykinin in rabbits, rats and mice","volume":"26","author":"Blais","year":"2005","journal-title":"Peptides."},{"issue":"8\u20139","key":"10.1016\/j.npep.2019.101998_bb0030","first-page":"520","article-title":"Modulation of the cannabinoid receptors by hemopressin peptides","volume":"92","author":"Bomar","year":"2014","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.npep.2019.101998_bb0035","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1021\/bm201836f","article-title":"Hemopressin forms self-assembled Fibrillar nanostructures under physiologically relevant conditions","volume":"13","author":"Bomar","year":"2012","journal-title":"Biomacromolecules."},{"key":"10.1016\/j.npep.2019.101998_bb0040","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jprot.2014.03.043","article-title":"Peptidomic analysis of the neurolysin-knockout mouse brain","volume":"111","author":"Castro","year":"2014","journal-title":"J. Proteome"},{"issue":"8","key":"10.1016\/j.npep.2019.101998_bb0045","doi-asserted-by":"crossref","first-page":"PL113","DOI":"10.1016\/S0024-3205(98)00322-1","article-title":"Appetite suppression and weight loss after the cannabinoid antagonist SR 141716","volume":"63","author":"Colombo","year":"1998","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.npep.2019.101998_bb0050","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/1570159043476963","article-title":"Cannabinoid receptor activation and the endocannabinoid system in the gastrointestinal tract","volume":"2","author":"Coutts","year":"2004","journal-title":"Curr. Neuropharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.npep.2019.101998_bb0055","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1590\/S0074-02762005000900017","article-title":"Hemopressin: a novel bioactive peptide derived from the alpha1-chain of hemoglobin","volume":"100","author":"Dale","year":"2005","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"3","key":"10.1016\/j.npep.2019.101998_bb0060","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.peptides.2004.10.026","article-title":"Antinociceptive action of hemopressin in experimental hyperalgesia","volume":"26","author":"Dale","year":"2005","journal-title":"Peptides."},{"issue":"5","key":"10.1016\/j.npep.2019.101998_bb0065","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1111\/j.1471-4159.1992.tb11021.x","article-title":"Endopeptidase 24-16 in Murines: tissue distribution, cerebral regionalization, and ontogeny","volume":"59","author":"Dauch","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.npep.2019.101998_bb0070","series-title":"Drug-like Properties: Concepts, Structure Design and Methods from ADME to Toxicity Optimization","author":"Di","year":"2016"},{"issue":"21","key":"10.1016\/j.npep.2019.101998_bb0075","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1523\/JNEUROSCI.5455-09.2010","article-title":"The peptide Hemopressin acts through CB1 cannabinoid receptors to reduce food intake in rats and mice","volume":"30","author":"Dodd","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2019.101998_bb0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuropharm.2013.03.007","article-title":"Central functional response to the novel peptide cannabinoid, hemopressin","volume":"71","author":"Dodd","year":"2013","journal-title":"Neuropharmacology."},{"issue":"NOV","key":"10.1016\/j.npep.2019.101998_bb0090","first-page":"58","article-title":"Disordered peptides looking for their native environment: structural basis of CB1 endocannabinoid receptor binding to pepcans","volume":"5","author":"Emendato","year":"2018","journal-title":"Front. Mol. Biosci."},{"issue":"5","key":"10.1016\/j.npep.2019.101998_bb0095","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cell.2004.11.025","article-title":"Molecular mechanism of AHSP-mediated stabilization of \u03b1-Hemoglobin","volume":"119","author":"Feng","year":"2004","journal-title":"Cell."},{"key":"10.1016\/j.npep.2019.101998_bb0100","series-title":"Endocannabinoids","first-page":"233","article-title":"Neurodegenerative disorders: Parkinson\u2019s disease, Huntington\u2019s chorea, Alzheimer\u2019s disease, and others","author":"Fern\u00e1ndez-Ruiz","year":"2015"},{"issue":"4","key":"10.1016\/j.npep.2019.101998_bb0105","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pbb.2014.11.013","article-title":"Anxiogenic-like effects induced by hemopressin in rats","volume":"129","author":"Foga\u00e7a","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.npep.2019.101998_bb0110","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20780.x","article-title":"Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations","volume":"232","author":"Gali\u00e8gue","year":"1995","journal-title":"Eur. J. Biochem."},{"issue":"4","key":"10.1016\/j.npep.2019.101998_bb0115","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/104454999315385","article-title":"Confocal microscopy reveals Thimet Oligopeptidase (EC 3.4.24.15) and Neurolysin (EC 3.4.24.16) in the classical secretory pathway","volume":"18","author":"Garrido","year":"1999","journal-title":"DNA Cell Biol."},{"issue":"3","key":"10.1016\/j.npep.2019.101998_bb0120","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1208\/s12248-010-9186-0","article-title":"Hemopressin and other bioactive peptides from cytosolic proteins: are these non-classical neuropeptides?","volume":"12","author":"Gelman","year":"2010","journal-title":"AAPS J."},{"issue":"4","key":"10.1016\/j.npep.2019.101998_bb0125","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1471-4159.2010.06653.x","article-title":"Hemopressins and other hemoglobin-derived peptides in mouse brain: comparison between brain, blood, and heart peptidome and regulation in Cpe fat\/fat mice","volume":"113","author":"Gelman","year":"2010","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.npep.2019.101998_bb0130","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.bbapap.2013.01.043","article-title":"Analysis of peptides secreted from cultured mouse brain tissue","volume":"1834","author":"Gelman","year":"2013","journal-title":"Biochim Biophys Acta - Proteins Proteomics."},{"issue":"1","key":"10.1016\/j.npep.2019.101998_bb0135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/002215540305100115","article-title":"Localization of EP24.15, a major liver Kininase","volume":"51","author":"Gioli-Pereira","year":"2003","journal-title":"J. Histochem. Cytochem."},{"issue":"9","key":"10.1016\/j.npep.2019.101998_bb0140","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1096\/fj.09-132142","article-title":"Novel endogenous peptide agonists of cannabinoid receptors","volume":"23","author":"Gomes","year":"2009","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.npep.2019.101998_bb0145","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1208\/s12248-010-9217-x","article-title":"Hemoglobin-derived peptides as novel type of bioactive Signaling molecules","volume":"12","author":"Gomes","year":"2010","journal-title":"AAPS J."},{"issue":"1\u20132","key":"10.1016\/j.npep.2019.101998_bb0150","first-page":"14","article-title":"Pharmacology of cannabinoids","volume":"25","author":"Grotenhermen","year":"2004","journal-title":"Neuroendocrinol. Lett."},{"key":"10.1016\/j.npep.2019.101998_bb0155","series-title":"Brain Targeted Drug Delivery System","first-page":"7","article-title":"Anatomy and physiology of blood-brain barrier","author":"Gupta","year":"2019"},{"issue":"2","key":"10.1016\/j.npep.2019.101998_bb0160","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.pbb.2011.09.004","article-title":"Centrally mediated antinociceptive effects of cannabinoid receptor ligands in rat models of nociception","volume":"100","author":"Hama","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.npep.2019.101998_bb0170","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/jpet.113.209866","article-title":"Antinociceptive effects of central Administration of the Endogenous Cannabinoid Receptor Type 1 agonist VDPVNFKLLSH-OH [(m)VD-hemopressin( \u03b1 )], an N-terminally extended Hemopressin peptide","volume":"348","author":"Han","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"51","key":"10.1016\/j.npep.2019.101998_bb0175","doi-asserted-by":"crossref","first-page":"20588","DOI":"10.1073\/pnas.0706980105","article-title":"Hemopressin is an inverse agonist of CB1 cannabinoid receptors","volume":"104","author":"Heimann","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.npep.2019.101998_bb0180","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neuropharm.2015.03.021","article-title":"Localization and production of peptide endocannabinoids in the rodent CNS and adrenal medulla","volume":"98","author":"Hofer","year":"2015","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.npep.2019.101998_bb0185","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/bs.apha.2017.03.007","article-title":"CB 1 and CB 2 receptor pharmacology","author":"Howlett","year":"2017","journal-title":"Adv. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.npep.2019.101998_bb0190","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0009-3084(00)00187-0","article-title":"Cellular signal transduction by anandamide and 2-arachidonoylglycerol","volume":"108","author":"Howlett","year":"2000","journal-title":"Chem. Phys. Lipids"},{"issue":"Suppl. 1","key":"10.1016\/j.npep.2019.101998_bb0195","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.neuropharm.2004.07.030","article-title":"Cannabinoid physiology and pharmacology: 30 years of progress","volume":"47","author":"Howlett","year":"2004","journal-title":"Neuropharmacology."},{"issue":"5","key":"10.1016\/j.npep.2019.101998_bb0200","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MNH.0000000000000249","article-title":"Cannabinoid receptors in the kidney","volume":"25","author":"Hryciw","year":"2016","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"3","key":"10.1016\/j.npep.2019.101998_bb0205","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.cell.2016.10.004","article-title":"Crystal structure of the human cannabinoid receptor CB1","volume":"167","author":"Hua","year":"2016","journal-title":"Cell."},{"issue":"9","key":"10.1016\/j.npep.2019.101998_bb0210","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2174\/1381612033455459","article-title":"Properties and distribution of angiotensin I converting enzyme","volume":"9","author":"Igic","year":"2003","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.npep.2019.101998_bb0215","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/(SICI)1097-0282(1997)43:2<171::AID-BIP10>3.0.CO;2-O","article-title":"Hemoglobin as a source of endogenous bioactive peptides: the concept of tissue-specific peptide pool","volume":"43","author":"Ivanov","year":"1997","journal-title":"Biopolymers."},{"issue":"1","key":"10.1016\/j.npep.2019.101998_bb0220","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pharmthera.2009.12.005","article-title":"Cannabinoids and the gut: new developments and emerging concepts","volume":"126","author":"Izzo","year":"2010","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.npep.2019.101998_bb0225","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cmet.2007.12.007","article-title":"Paracrine activation of hepatic CB1 receptors by stellate cell-derived Endocannabinoids mediates alcoholic fatty liver","volume":"7","author":"Jeong","year":"2008","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.npep.2019.101998_bb0230","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1053\/j.gastro.2004.12.050","article-title":"Antifibrogenic role of the cannabinoid receptor CB2 in the liver","volume":"128","author":"Julien","year":"2005","journal-title":"Gastroenterology."},{"issue":"3","key":"10.1016\/j.npep.2019.101998_bb0235","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/jnr.10779","article-title":"Novel roles of neuropeptide processing enzymes: EC3.4.24.15 in the neurome","volume":"74","author":"Kim","year":"2003","journal-title":"J. Neurosci. Res."},{"issue":"6","key":"10.1016\/j.npep.2019.101998_bb0240","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1074\/jbc.274.6.3363","article-title":"The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes","volume":"274","author":"Kisselev","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"19","key":"10.1016\/j.npep.2019.101998_bb0245","doi-asserted-by":"crossref","first-page":"6859","DOI":"10.1039\/C4CS00047A","article-title":"Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids","volume":"43","author":"Kohnz","year":"2014","journal-title":"Chem. Soc. Rev."},{"issue":"1\u20132","key":"10.1016\/j.npep.2019.101998_bb0250","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0014-5793(91)80011-Q","article-title":"Hemorphins derived from hemoglobin have an inhibitory action on angiotensin converting enzyme activity","volume":"287","author":"Lantz","year":"1991","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.npep.2019.101998_bb0255","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.pharep.2017.06.010","article-title":"Emotional disorders induced by Hemopressin and RVD-hemopressin(\u03b1) administration in rats","volume":"69","author":"Leone","year":"2017","journal-title":"Pharmacol Reports."},{"key":"10.1016\/j.npep.2019.101998_bb0260","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.npep.2018.10.002","article-title":"Effects of RVD-hemopressin (\u03b1) on feeding and body weight after standard or cafeteria diet in rats","volume":"72","author":"Leone","year":"2018","journal-title":"Neuropeptides."},{"issue":"3","key":"10.1016\/j.npep.2019.101998_bb0265","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cell.2018.12.011","article-title":"Crystal structure of the human cannabinoid receptor CB2","volume":"176","author":"Li","year":"2019","journal-title":"Cell."},{"key":"10.1016\/j.npep.2019.101998_bb0270","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.peptides.2014.03.012","article-title":"The hypotensive effect of intrathecally injected (m)VD-hemopressin(\u03b1) in urethane-anesthetized rats","volume":"56","author":"Li","year":"2014","journal-title":"Peptides."},{"issue":"6","key":"10.1016\/j.npep.2019.101998_bb0275","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/nmo.12789","article-title":"Central administrations of hemopressin and related peptides inhibit gastrointestinal motility in mice","volume":"28","author":"Li","year":"2016","journal-title":"Neurogastroenterol. Motil."},{"issue":"9","key":"10.1016\/j.npep.2019.101998_bb0280","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/j.peptides.2006.04.010","article-title":"Hemopressin, a hemoglobin fragment, dilates the rat systemic vascular bed through release of nitric oxide","volume":"27","author":"Lippton","year":"2006","journal-title":"Peptides."},{"issue":"5","key":"10.1016\/j.npep.2019.101998_bb0285","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1053\/j.gastro.2012.01.032","article-title":"Hepatic cannabinoid Receptor-1 mediates diet-induced insulin resistance via inhibition of insulin Signaling and clearance in mice","volume":"142","author":"Liu","year":"2012","journal-title":"Gastroenterology."},{"issue":"3","key":"10.1016\/j.npep.2019.101998_bb0290","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cell.2019.01.012","article-title":"Receptor structures for a caldron of cannabinoids","volume":"176","author":"Lorenzen","year":"2019","journal-title":"Cell."},{"issue":"1","key":"10.1016\/j.npep.2019.101998_bb0295","article-title":"Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions","volume":"5","author":"Ma","year":"2015","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.npep.2019.101998_bb0300","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2174\/0929866523666161007152435","article-title":"Hemopressin peptides as modulators of the endocannabinoid system and their potential applications as therapeutic tools","volume":"23","author":"Macedonio","year":"2016","journal-title":"Protein Pept Lett."},{"key":"10.1016\/j.npep.2019.101998_bb0305","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejphar.2014.08.021","article-title":"Role of cannabinoid receptors in hepatic fibrosis and apoptosis associated with bile duct ligation in rats","volume":"742","author":"Mahmoud","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.npep.2019.101998_bb0310","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0163-7258(02)00254-1","article-title":"Study of cannabinoid dependence in animals","volume":"95","author":"Maldonado","year":"2002","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.npep.2019.101998_bb0315","first-page":"G9","article-title":"Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liver","volume":"294","author":"Mallat","year":"2008","journal-title":"Am J Physiol Liver Physiol."},{"issue":"6","key":"10.1016\/j.npep.2019.101998_bb0320","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.tips.2004.04.005","article-title":"Signaling pathways involved in the development of cannabinoid tolerance","volume":"25","author":"Martin","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.npep.2019.101998_bb0325","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1021\/cn100005p","article-title":"Cannabinoid conditioned reward and aversion: behavioral and neural processes","volume":"1","author":"Murray","year":"2010","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.npep.2019.101998_bb0330","doi-asserted-by":"crossref","unstructured":"Norman MU, Smith AI, Hickey MJ. Metalloendopeptidases EC 3.4.24.15 and EC 3.4.24.16: Potential roles in vascular physiology. In: Letters in Peptide Science. Vol 8. ; 2001:195\u2013199. doi:https:\/\/doi.org\/10.1023\/A:1016289416382","DOI":"10.1023\/A:1016289416382"},{"issue":"9","key":"10.1016\/j.npep.2019.101998_bb0335","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/febs.12260","article-title":"Modulating the endocannabinoid system in human health and disease - successes and failures","volume":"280","author":"Pacher","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.npep.2019.101998_bb0340","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejphar.2015.10.016","article-title":"Effects of neuropeptide FF and related peptides on the antinociceptive activities of VD-hemopressin(\u03b1) in naive and cannabinoid-tolerant mice","volume":"767","author":"Pan","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2019.101998_bb0345","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neulet.2014.06.058","article-title":"Analgesic tolerance and cross-tolerance to the cannabinoid receptors ligands hemopressin, VD-hemopressin(\u03b1) and WIN55,212-2 at the supraspinal level in mice","volume":"578","author":"Pan","year":"2014","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.npep.2019.101998_bb0350","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRX."},{"issue":"1","key":"10.1016\/j.npep.2019.101998_bb0360","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-09808-8","article-title":"Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator constitutively secreted by adrenals and in liver upon tissue damage","volume":"7","author":"Petrucci","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.npep.2019.101998_bb0365","series-title":"Endocannabinoids","first-page":"213","article-title":"Amyotrophic lateral Sclerosis","author":"Pryce","year":"2015"},{"issue":"4","key":"10.1016\/j.npep.2019.101998_bb0370","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.pharep.2018.01.010","article-title":"Effects of central RVD-hemopressin(\u03b1) administration on anxiety, feeding behavior and hypothalamic neuromodulators in the rat","volume":"70","author":"Recinella","year":"2018","journal-title":"Pharmacol Reports."},{"key":"10.1016\/j.npep.2019.101998_bb0375","first-page":"1","article-title":"Synthesis of hemopressin peptides by classical solution phase fragment condensation","volume":"2012","author":"Reddy","year":"2012","journal-title":"Int. J. Pept."},{"issue":"45","key":"10.1016\/j.npep.2019.101998_bb0380","doi-asserted-by":"crossref","first-page":"18267","DOI":"10.1039\/C6DT03598A","article-title":"DOES hemopressin bind metal ions in vivo?","volume":"45","author":"Remelli","year":"2016","journal-title":"Dalt Trans."},{"issue":"5","key":"10.1016\/j.npep.2019.101998_bb0385","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/cne.22062","article-title":"Neurons express hemoglobin \u03b1- and \u03b2-chains in rat and human brains","volume":"515","author":"Richter","year":"2009","journal-title":"J. Comp. Neurol."},{"issue":"10","key":"10.1016\/j.npep.2019.101998_bb0390","doi-asserted-by":"crossref","first-page":"8547","DOI":"10.1074\/jbc.M212030200","article-title":"Novel natural peptide substrates for endopeptidase 24.15, Neurolysin, and angiotensin-converting enzyme","volume":"278","author":"Rioli","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.npep.2019.101998_bb0395","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1096\/fj.07-102731","article-title":"Regulation of CB 1 cannabinoid receptor trafficking by the adaptor protein AP-3","volume":"22","author":"Rozenfeld","year":"2008","journal-title":"FASEB J."},{"issue":"16","key":"10.1016\/j.npep.2019.101998_bb0400","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1111\/j.1742-4658.2009.07144.x","article-title":"Interaction with calmodulin is important for the secretion of thimet oligopeptidase following stimulation","volume":"276","author":"Russo","year":"2009","journal-title":"FEBS J."},{"issue":"19","key":"10.1016\/j.npep.2019.101998_bb0405","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1111\/bph.13050","article-title":"The endocannabinoid system in renal cells: regulation of Na + transport by CB 1 receptors through distinct cell signalling pathways","volume":"172","author":"Sampaio","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2019.101998_bb0410","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.nlm.2016.07.030","article-title":"Effects of the cannabinoid 1 receptor peptide ligands hemopressin, (m)RVD-hemopressin(\u03b1) and (m)VD-hemopressin(\u03b1) on memory in novel object and object location recognition tasks in normal young and A\u03b2 1\u201342 -treated mice","volume":"134","author":"San","year":"2016","journal-title":"Neurobiol. Learn. Mem."},{"issue":"3","key":"10.1016\/j.npep.2019.101998_bb0415","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/jcbfm.2008.152","article-title":"Expression of Hemoglobin in rodent neurons","volume":"29","author":"Schelshorn","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.npep.2019.101998_bb0420","series-title":"Encyclopedia of Psychopharmacology","first-page":"45","article-title":"Agonist","author":"Scherrmann","year":"2010"},{"issue":"7634","key":"10.1016\/j.npep.2019.101998_bb0425","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nature20613","article-title":"High-resolution crystal structure of the human CB1 cannabinoid receptor","volume":"540","author":"Shao","year":"2016","journal-title":"Nature."},{"issue":"2\u20133","key":"10.1016\/j.npep.2019.101998_bb0430","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejphar.2011.02.023","article-title":"Endogenously generated 2-arachidonoylglycerol plays an inhibitory role in bombesin-induced activation of central adrenomedullary outflow in rats","volume":"658","author":"Shimizu","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.npep.2019.101998_bb0435","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/cbdd.12610","article-title":"Site-specific substitutions eliminate aggregation properties of Hemopressin","volume":"86","author":"Song","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.npep.2019.101998_bb0440","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.phrs.2015.07.017","article-title":"Aiming for allosterism: evaluation of allosteric modulators of CB<inf>1<\/inf> in a neuronal model","volume":"99","author":"Straiker","year":"2015","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.npep.2019.101998_bb0445","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lungcan.2004.10.007","article-title":"Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time polymerase chain reaction","volume":"48","author":"Sueoka","year":"2005","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.npep.2019.101998_bb0450","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.nano.2011.06.003","article-title":"Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome","volume":"8","author":"Szebeni","year":"2012","journal-title":"Nanomedicine Nanotechnology, Biol Med."},{"issue":"6","key":"10.1016\/j.npep.2019.101998_bb0455","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1213\/ANE.0000000000000964","article-title":"Further characterization of Hemopressin peptide fragments in the opioid and cannabinoid systems","volume":"121","author":"Szlavicz","year":"2015","journal-title":"Anesth. Analg."},{"issue":"1","key":"10.1016\/j.npep.2019.101998_bb0460","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/bph.12471","article-title":"Brain RVD-haemopressin, a haemoglobin-derived peptide, inhibits bombesin-induced central activation of adrenomedullary outflow in the rat","volume":"171","author":"Tanaka","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.npep.2019.101998_bb0465","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0014-5793(94)00665-2","article-title":"Existence of a molecular ruler in proteasomes suggested by analysis of degradation products","volume":"349","author":"Wenzel","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.npep.2019.101998_bb0470","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neuroscience.2015.10.015","article-title":"Intracellular postsynaptic cannabinoid receptors link thyrotropin-releasing hormone receptors to TRPC-like channels in thalamic paraventricular nucleus neurons","volume":"311","author":"Zhang","year":"2015","journal-title":"Neuroscience."},{"key":"10.1016\/j.npep.2019.101998_bb0475","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neuroscience.2016.02.047","article-title":"Endocannabinoid 2-AG and intracellular cannabinoid receptors modulate a low-threshold calcium spike-induced slow depolarizing afterpotential in rat thalamic paraventricular nucleus neurons","volume":"322","author":"Zhang","year":"2016","journal-title":"Neuroscience."},{"key":"10.1016\/j.npep.2019.101998_bb0480","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.npep.2016.12.006","article-title":"Pharmacological characterization of rat VD-hemopressin(\u03b1), an \u03b1-hemoglobin-derived peptide exhibiting cannabinoid agonist-like effects in mice","volume":"63","author":"Zheng","year":"2017","journal-title":"Neuropeptides."},{"key":"10.1016\/j.npep.2019.101998_bb0485","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.brainres.2017.12.013","article-title":"CB1 cannabinoid receptor agonist mouse VD-hemopressin(\u03b1) produced supraspinal analgesic activity in the preclinical models of pain","volume":"1680","author":"Zheng","year":"2018","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.npep.2019.101998_bb0490","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.peptides.2012.08.006","article-title":"Effects of endokinin A\/B and endokinin C\/D on the antinociception properties of hemopressin in mice","volume":"38","author":"Zhou","year":"2012","journal-title":"Peptides."}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417919300794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417919300794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T20:38:58Z","timestamp":1758919138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143417919300794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":95,"alternative-id":["S0143417919300794"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2019.101998","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Signaling molecules targeting cannabinoid receptors: Hemopressin and related peptides","name":"articletitle","label":"Article Title"},{"value":"Neuropeptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.npep.2019.101998","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101998"}}